New research from the Center for Disease Control and Prevention indicates that by early fall 2022, an overwhelming percentage of American adults had antibodies to SARS-CoV-2, the virus that causes COVID-19. According to the study, 96% of 72,748 blood donors aged 16 years and older included in the study had antibodies. Of that group, 23% acquired their immunity from infection alone and 26% from vaccination alone; 48% had hybrid immunity. Researchers say a low prevalence of infection-induced hybrid immunity among older adults reaffirms the importance of this group staying up to date on their vaccination and gaining easy access to antiviral treatments, since they are at increased risk of severe COVID-19. 
 

Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…